Liyuan Ke
No. 103, Wenhua Road
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: July 18, 2025
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: March 13, 2025
Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: April 08, 2024
Perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials.
Journal: International immunopharmacology
Published: January 10, 2024
Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis.
Journal: BMC cancer
Published: December 30, 2023
Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
Journal: BMC women's health
Published: July 29, 2023
The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Journal: International immunopharmacology
Published: March 15, 2023
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials.
Journal: BMC cancer
Published: February 22, 2023
The π-π stacking-guided supramolecular self-assembly of nanomedicine for effective delivery of antineoplastic therapies.
Journal: Nanomedicine (London, England)
Published: November 10, 2018
Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 18, 2017
Last Updated: 09/26/2026